Mckesson (MCK) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026)
Mckesson (MCK) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
- |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
37.60% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
128.26% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
-19.52% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
4.55% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
-60.00% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
-20.00% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
-400.00% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-100.00% |
| 10 |
Cellyan Biotechnology |
5.69 |
-2.48 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
37.60% |
| Dec 31, 2025 |
37.99% |
| Sep 30, 2025 |
377.01% |
| Jun 30, 2025 |
-10.71% |
| Mar 31, 2025 |
65.33% |
| Dec 31, 2024 |
57.24% |
| Sep 30, 2024 |
-61.99% |
| Jun 30, 2024 |
-0.28% |
| Mar 31, 2024 |
4.35% |
| Dec 31, 2023 |
-42.22% |
| Sep 30, 2023 |
-23.36% |
| Jun 30, 2023 |
33.71% |
| Mar 31, 2023 |
135.66% |
| Dec 31, 2022 |
19,225.00% |
| Sep 30, 2022 |
275.44% |
| Jun 30, 2022 |
71.01% |
| Mar 31, 2022 |
-41.20% |
| Dec 31, 2021 |
99.90% |
| Sep 30, 2021 |
-51.69% |
| Jun 30, 2021 |
12.87% |
